Valeant Pharmaceuticals International Inc said it is prepared to improve its offer for Allergan Inc to at least $200 per share. The Botox maker's shares closed at $184.21 on Friday.Valeant Chief Executive Michael Pearson said in a letter to Allergan's board that Allergan's stock would not be trading at the multiples it is now if it were not for Valeant's offer.Pearson told Reuters last week that a possible revised stock-and-cash bid would be worth more than $200 per share, assuming that Valeant's stock rises, and would include more cash.
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN traded higher by 0.46% or $0.84/share to $184.21. In the past year, the shares have traded as low as $88.34 and as high as $192.98. On average, 2284750 shares of AGN exchange hands on a given day and today's volume is recorded at 1757545.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 0.87% or $1.11/share to $129.13. In the past year, the shares have traded as low as $102.60 and as high as $153.10. On average, 2836580 shares of VRX exchange hands on a given day and today's volume is recorded at 1831757.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 0.84% or $1.21/share to $145.21. In the past year, the shares have traded as low as $107.30 and as high as $170.45. On average, 482480 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 350697.
Source
